Johnson & Johnson JNJ
NYSE JNJ
$276.19 +3.87 (+1.42%)
As of: Nov 6, 2026 · 3:59 PM EST

Johnson & Johnson (JNJ) Long-Term Investments (2009)

Updated

Analysis

Johnson & Johnson (JNJ) Long-Term Investments (2009) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 387.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 63.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 268.00 Mn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 1.45 Bn
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 3.52 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2009 19.00 Mn
Jun 28, 2009 18.00 Mn
API Access

Johnson & Johnson Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=JNJ&period=max&api_key=YOUR_API_KEY